Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1993-11-12
1994-10-04
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514967, A61K 3120
Patent
active
053526996
ABSTRACT:
A method for the treatment of vaginal atrophy in a human patient in which retinoic acid is administered topically to the patient's vagina.
REFERENCES:
CA 108(5):36588k, Silva et al., 1987.
CA 98(9):70742r, Stephens-Jarnagin et al., 1983.
Cintins Marianne M.
Jordan Kimberly R.
University of Massachusetts Medical Center
LandOfFree
Use of retinioc acid to treat vaginal atrophy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of retinioc acid to treat vaginal atrophy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of retinioc acid to treat vaginal atrophy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-581568